These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26242783)

  • 1. Comment and Completion: Implementation of Parallelism Testing for Four-Parameter Logistic Model in Bioassays.
    Sondag P; Joie R; Yang H
    PDA J Pharm Sci Technol; 2015; 69(4):467-70. PubMed ID: 26242783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of parallelism testing for four-parameter logistic model in bioassays.
    Yang H; Kim HJ; Zhang L; Strouse RJ; Schenerman M; Jiang XR
    PDA J Pharm Sci Technol; 2012; 66(3):262-9. PubMed ID: 22634591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalence testing for parallelism in the four-parameter logistic model.
    Jonkman JN; Sidik K
    J Biopharm Stat; 2009 Sep; 19(5):818-37. PubMed ID: 20183446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast and reliable test for parallelism in bioassay.
    Novick S; Yang H
    J Biopharm Stat; 2019; 29(6):1011-1023. PubMed ID: 30712462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for parallelism in the heteroscedastic four-parameter logistic model.
    Sidik K; Jonkman JN
    J Biopharm Stat; 2016; 26(2):250-68. PubMed ID: 25629201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parallelism in practice: approaches to parallelism in bioassays.
    Fleetwood K; Bursa F; Yellowlees A
    PDA J Pharm Sci Technol; 2015; 69(2):248-63. PubMed ID: 25868991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Generic Equivalence Margins for Early-Stage Implementation of Equivalence Testing for Potency Assays.
    Pflanzner T; Duan Y; Bui UN; Zhang L; Hartman SE; Kron M
    PDA J Pharm Sci Technol; 2021; 75(2):173-187. PubMed ID: 32999078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A curve similarity approach to parallelism testing in bioassay.
    Faya P; Rauk AP; Griffiths KL; Parekh B
    J Biopharm Stat; 2020 Jul; 30(4):721-733. PubMed ID: 32163316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new parallelism acceptance criterion for validating large plate bioassay results.
    Story MJ; Winson JA; Beyer PL; Boehm G
    J Biol Stand; 1986 Jul; 14(3):249-54. PubMed ID: 3759999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data.
    Gottschalk PG; Dunn JR
    J Biopharm Stat; 2005; 15(3):437-63. PubMed ID: 15920890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a statistical outlier in potency bioassays.
    Sondag P; Zeng L; Yu B; Rousseau R; Boulanger B; Yang H; Novick S
    Pharm Stat; 2018 Nov; 17(6):701-709. PubMed ID: 30112804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing drug additivity based on monotherapies.
    Yang H; Novick SJ; Zhao W
    Pharm Stat; 2015; 14(4):332-40. PubMed ID: 25962689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of parallelism and nonparallelism in bioassay dilution curves.
    Plikaytis BD; Holder PF; Pais LB; Maslanka SE; Gheesling LL; Carlone GM
    J Clin Microbiol; 1994 Oct; 32(10):2441-7. PubMed ID: 7814480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized confidence intervals for ratios of regression coefficients with applications to bioassays.
    Bebu I; Seillier-Moiseiwitsch F; Mathew T
    Biom J; 2009 Dec; 51(6):1047-58. PubMed ID: 19894218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal designs for asymmetric sigmoidal response curves in bioassays and immunoassays.
    Hyun SW; Wong WK; Yang Y
    Stat Methods Med Res; 2020 Feb; 29(2):421-436. PubMed ID: 30868935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the four-parameter logistic model to bioassay: comparison with slope ratio and parallel line models.
    Vølund A
    Biometrics; 1978 Sep; 34(3):357-65. PubMed ID: 719119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing equivalence of two assays using sensitivity and specificity.
    Quiroz J; Burdick RK
    J Biopharm Stat; 2007; 17(3):433-43. PubMed ID: 17479392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algorithm for robust non-linear analysis of radioimmunoassays and other bioassays.
    Normolle DP
    Stat Med; 1993 Nov; 12(21):2025-42. PubMed ID: 8296112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel dose-response curves in combination experiments.
    Sühnel J
    Bull Math Biol; 1998 Mar; 60(2):197-213. PubMed ID: 9559575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.